Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Treasury Shares (2020 - 2023)

Cullinan Therapeutics has reported Treasury Shares over the past 3 years, most recently at $85.6 million for Q3 2023.

  • Quarterly results put Treasury Shares at $85.6 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $85.6 million (changed N/A YoY), and the annual figure for FY2022 was $369000.0, changed.
  • Treasury Shares for Q3 2023 was $85.6 million at Cullinan Therapeutics, roughly flat from $85.6 million in the prior quarter.
  • Over the last five years, Treasury Shares for CGEM hit a ceiling of $85.6 million in Q2 2023 and a floor of $364000.0 in Q4 2020.
  • Median Treasury Shares over the past 3 years was $43.0 million (2022), compared with a mean of $43.0 million.